Per PR from 5/22, peptides need to pass Quality As
Post# of 36537
https://www.globenewswire.com/news-release/20...tides.html
Once the peptides pass Quality Assurance testing, they will be shipped to the clinical laboratories conducting the “Ex-Vivo” Human Immune System Screening Program using blood and plasma samples from patients who have recovered from COVID-19 that have already been collected and stored for the screening program.
Buildit wrote -
Well, he already DID provide a specific answer of where they are in the process, whether he likes it or not:
“Also, we are poised to begin testing Ii-Key-SARS-CoV-2 peptides against blood samples...”
Poised to start means it has not started, in a fairly definitive way. If that is not where they are, it would seem he could have stated this differently, while making a public statement.
So, intentionally or not, he has implied we are at a standstill until funding breaks.
Read More: https://investorshangout.com/post/view?id=581...z6Qy6nCusX
Read More: https://investorshangout.com/post/newpost/622...z6QyACRC5o